Jan Hartmann, M.D.

@janhartmannmd.bsky.social

Bringing Med to MedTech - Physician, Scientist, Photographer, Traveler, Berliner, Immigrant đŸ‡©đŸ‡ȘđŸ‡ș🇾 - Views=My own, Like/RT≠Endorsement; Haemonetics employee

Monoclonal gammopathy of undetermined significance is a common, asymptomatic plasma-cell disorder in older adults that can progress to cancer or systemic illness. Diagnosis warrants follow-up, but treatment is not required unless progression is confirmed. Learn more: nej.md/473uOsj

An illustrated diagram of the pathogenesis and progression of monoclonal gammopathy of undetermined significance (MGUS).

In the BATURA phase 3b trial, as-needed albuterol–budesonide resulted in a lower risk of severe asthma exacerbation than as-needed albuterol among participants with disease that was uncontrolled despite treatment for mild asthma. Full trial results and Research Summary: nej.md/43uVpwK

The New England Journal of Medicine              
As-Needed Albuterol–Budesonide in Mild Asthma 
A Research Summary based on LaForce C et al. | 10.1056/NEJMoa2504544 | Published on May 19, 2025  

Visual representations of the patients in the trial and the treatments they were assigned.                  

Read the full Research Summary at NEJM.org.

This tiny device can shrink dangerous blood clots. It’s called the ‘milli-spinner’ and its invention was partly an accident